Purging of peripheral blood progenitor cells

Annals of Oncology

Volumn 7, Issue SUPPL. 2, 1996, Pages 11-13

  Brugger, W ^a   Scheding, S ^a   Vogel, W ^b   Kanz, L ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Breast neoplasms; CD34+ cells; Chemotherapy; Cytokines; Dose intensity; Ex vivo purging; In vivo purging; Peripheral blood progenitor cells; Small cell lung cancer; Transplantation

Indexed keywords

ANTINEOPLASTIC AGENT; CD34 ANTIGEN;

BLOOD; BONE MARROW PURGING; CELL CULTURE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; METHODOLOGY; MULTIMODALITY CANCER THERAPY; NEOPLASM; REVIEW;

ANTIGENS, CD34; ANTINEOPLASTIC AGENTS; BONE MARROW PURGING; CELLS, CULTURED; COMBINED MODALITY THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMANS; NEOPLASMS;

EID: 2342463111     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/7.suppl_2.11     Document Type: Review

References (23)

1. Shpall EJ, Jones RB. Release of tumour cells from bone marrow. Blood 1994; 83: 623-5.
2. Moss TJ, Sanders DG, Lasky LC et al. Contamination of peripheral blood stem cell harvests by circulating neuroblastoma cells. Blood 1990; 76: 1879-83.
3. Ross AA, Cooper BW, Lazarus HM et al. Detection and viability of tumour cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques. Blood 1993; 82: 2605-10.
4. Brugger W, Bross KJ, Glatt M et al. Mobilization of tumour cells and haematopoietic progenitor cells into peripheral blood of patients with solid tumours. Blood 1994; 83: 636-40.
5. Straka C, Kroner C, Dörken B et al. Polymerase chain reaction monitoring shows a high efficacy of clinical immunomagnetic purging in patients with centroblastic-centrocytic non-Hodgkin's lymphoma. Blood 1992; 80: 2688-90.
6. Sharp JG, Joshi SS, Armitage JO et al. Significance of detection of occult non-Hodgkin's lymphoma in histologically uninvolved bone marrow by culture techniques. Blood 1992; 79: 1074-80.
7. Brenner MK, Rill DR, Moen RC et al. Gene-marking to trace origin of relapse after autologous bone-marrow transplantation. Lancet 1993; 341: 85-6.
8. Rill RD, Santan VM, Roberts WM et al. Direct demonstration that autologous bone marrow transplantation for solid tumours can return a multiplicity of tumourigenic cells. Blood 1994; 84: 380-3.
9. Deisseroth AB, Zu Z, Claxton D et al. Genetic marking shows that Ph+ cells present in autologous transplants of chronic myelogeneous leukemia (CML) contribute to relapse after autologous bone marrow in CML. Blood 1994; 83: 3068-76.
10. Brugger W, Bross KJ, Frisch J et al. Mobilization of peripheral blood progenitor cells by sequential administration of IL-3 and GM-CSF following chemotherapy with etoposide, ifosfamide, and cisplatin. Blood 1992; 79: 1193-200.
11. Haas R, Möhle R, Frühauf S et al. Patient characteristics associated with successful mobilizing and autografting of peripheral blood progenitor cells in malignant lymphoma. Blood 1994; 83: 3787-94.
12. Shpall EJ, Jones RB, Bearman SI et al. Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: Influence of CD34-positive peripheral blood progenitors and growth factors on engraftment. J Clin Oncol 1994; 12: 28-36.
13. Vescio RA, Hong HC, Cao J et al. The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood 1994; 84: 3283-90.
14. +-selected human peripheral blood progenitor cells. Blood 1994; 84: 2898-903.
15. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, ifosfamide, carboplatin, and epirubicin. Blood 1994; 84: 1421-6.
16. + selected progenitor cells from matched related donors: Results of a clinical phase I/II study. Blood 1995; 86: 290a.
17. + progenitor cells by stem cell factor, interleukin-1β, interleukin-6, interleukin-3, interferon-gamma, and erythropoietin. Blood 1993; 81: 2579-84.
18. Vaziri H, Dragowska W, Allsopp RC et al. Evidence for a mitotic clock in human hematopoietic stem cells: Loss of telomeric DNA with age. Proc Natl Acad Sci USA 1994; 91: 9857-60.
19. + cells from patients with stage IV breast cancer. Blood 1994; 84: 3567-74.
20. + progenitor cells. Blood 1995; 86: 295a.
21. Brugger W, Heimfeld S, Berenson RJ et al. Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Engl J Med 1995; 333: 283-7.
22. Bock TA, Orlic D, Dunbar CE et al. Improved engraftment of human hematopoietic cells in severe combined immunodeficient (SCID) mice carrying human cytokine transgenes. J Exp Med 1995; 182: 2037-43.
23. + hematopoietic progenitor cells in cancer patients. Eur J Immunol 1996; 26: in press.